$24.73
0.04% today
NYSE, Apr 02, 10:00 pm CET
ISIN
US3580291066
Symbol
FMS

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock price

$24.73
+1.18 5.01% 1M
+3.59 16.98% 6M
+2.09 9.23% YTD
+5.96 31.75% 1Y
-8.82 26.29% 3Y
-7.60 23.51% 5Y
-17.36 41.25% 10Y
NYSE, Closing price Wed, Apr 02 2025
-0.01 0.04%
ISIN
US3580291066
Symbol
FMS
Sector

Key metrics

Market capitalization $14.52b
Enterprise Value $25.74b
P/E (TTM) P/E ratio 24.87
EV/FCF (TTM) EV/FCF 14.11
EV/Sales (TTM) EV/Sales 1.23
P/S ratio (TTM) P/S ratio 0.69
P/B ratio (TTM) P/B ratio 0.96
Dividend yield 2.60%
Last dividend (FY24) $0.64
Revenue growth (TTM) Revenue growth -0.57%
Revenue (TTM) Revenue $20.91b
EBIT (operating result TTM) EBIT $1.77b
Free Cash Flow (TTM) Free Cash Flow $1.82b
Cash position $1.38b
EPS (TTM) EPS $0.99
P/E forward 13.72
P/S forward 0.69
EV/Sales forward 1.22
Short interest 0.20%
Show more

Is Fresenius Medical Care AG & Co. KGaA Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

8x Buy
36%
10x Hold
45%
4x Sell
18%

Analyst Opinions

22 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

Buy
36%
Hold
45%
Sell
18%

Financial data from Fresenius Medical Care AG & Co. KGaA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
20,912 20,912
1% 1%
100%
- Direct Costs 15,768 15,768
0% 0%
75%
5,144 5,144
3% 3%
25%
- Selling and Administrative Expenses 1,425 1,425
7% 7%
7%
- Research and Development Expense 198 198
21% 21%
1%
3,521 3,521
1% 1%
17%
- Depreciation and Amortization 1,752 1,752
1% 1%
8%
EBIT (Operating Income) EBIT 1,770 1,770
0% 0%
8%
Net Profit 584 584
8% 8%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Fresenius Medical Care AG & Co. KGaA Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock News

Neutral
PRNewsWire
20 days ago
In 2024, the operating model to deliver the highest quality of patient care was further optimized by enhancing financial returns, and creating value for shareholders Fresenius Medical Care delivered 18% operating income growth on an outlook base in 2024 Ongoing progress has been achieved in key areas of sustainability: notably in patient care and environmental footprint BAD HOMBURG, Germany , M...
Negative
Reuters
30 days ago
Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in the company.
Neutral
PRNewsWire
about one month ago
Organic revenue growth1 of 4% driven by Care Enablement and Care Delivery Underlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full year Accumulated savings of the FME25 program already reached EUR 567 million and 2025 target raised to EUR 750 million With 18% operating income2 growth top end of the 2024 outlook range reached Reported operating inco...
More Fresenius Medical Care AG & Co. KGaA Sponsored ADR News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office Germany
CEO Helen Giza
Employees 113,840
Founded 1996
Website www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today